Objective Although endocrine therapy using estrogen antagonist tamoxifen can effectively improve the survival rate of estrogen receptor-alpha(ERa)positive breast cancers,it has been demonstrated that
Objective Gastric cancer(GC),one of the most aggressive gastrointestinal malignancies,has high incidence and mortality rates worldwide,especially in Asia.